Phillip W.L. Tai

6.2k citations

53 papers · 4.1k indexed · 2 hit papers · h-index 25

Genetics top 0.5%
- Virus-based gene therapy research 34
Molecular Biology top 2%
- CRISPR and Genetic Engineering 19
- RNA Interference and Gene Delivery 14
- Viral Infectious Diseases and Gene Expression in Insects 12
- RNA Research and Splicing 8
- Bone Metabolism and Diseases 5
- Molecular Biology Techniques and Applications 4
Business and International Management top 5%
Oncology top 5%
- CAR-T cell therapy research 5
Genetics top 5%
- Virus-based gene therapy research 34

Co-authors: Guangping Gao Dan Wang Hong MaYi WangJote Bulcha Jun Xie Janet L. Stein Jane B. Lian
Cited by: Genetics Molecular Biology Business and International Management
Journals: Nucleic Acids Research (2 papers)Journal of Clinical Investigation (1 paper)Nature Communications (4 papers)
Partner nations: United States China France

In The Last Decade

Phillip W.L. Tai

50 papers receiving 4.0k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Phillip W.L. Tai

Since Specialization

Citations

This map shows the geographic impact of Phillip W.L. Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip W.L. Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip W.L. Tai more than expected).

Fields of papers citing papers by Phillip W.L. Tai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip W.L. Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip W.L. Tai. The network helps show where Phillip W.L. Tai may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Phillip W.L. Tai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Phillip W.L. Tai Line = papers co-authored together Phillip W.L. Tai links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	High-purity AAV vector production utilizing recombination-dependent minicircle formation and genetic coupling EMBO Molecular Medicine ·Hao Liu,Nan Liu,Chen Zhou,Ailing Du,Mayank Kapadia,Phillip W.L. Tai,Erik S. Barton,(unknown),Dan Wang	2025	0
2	A deep learning model trained on expressed transcripts across different tissue types reveals cell-type codon-optimization preferences Nucleic Acids Research ·S K RAVI,Tapan Sharma,Mitchell Yip,Huiya Yang,Jun Xie,Guangping Gao,Phillip W.L. Tai	2025	2
3	miR-375 protects against acetaminophen-induced acute liver failure by orchestrating pharmacogene expression Molecular Therapy ·Yì Wáng,Jinghua Liu,Sha Zhu,Shi-Liang Hu,X Chen,Elisabet Mandon,Ngan T.K. Tran,Sen-Yu Zhang,Yinliang Qi,Hong Ma,Ran He,Yu Cao,Qin Su,Timothy Gallagher,Zixiu Li,Chan Zhou,Phillip W.L. Tai,Guangping Gao,Jun Xie	2025	0
4	Profiling AAV vector heterogeneity & contaminants using next-generation sequencing methods Cell and Gene Therapy Insights ·Ngoc Tam Tran,Phillip W.L. Tai	2024	4
5	The AAV2.7m8 capsid packages a higher degree of heterogeneous vector genomes than AAV2 Gene Therapy ·Mengtian Cui,Qin Su,Mitchell Yip,Jackson McGowan,Claudio Punzo,Guangping Gao,Phillip W.L. Tai	2024	5
6	Querying Recombination Junctions of Replication-Competent Adeno-Associated Viruses in Gene Therapy Vector Preparations with Single Molecule, Real-Time Sequencing Viruses ·Mitchell Yip,Jing Chen,Yan Zhi,Ngoc Tam Tran,Suk Namkung,Eric Pastor,Guangping Gao,Phillip W.L. Tai	2023	4
7	Human and Insect Cell-Produced Recombinant Adeno-Associated Viruses Show Differences in Genome Heterogeneity Human Gene Therapy ·Ngoc Tam Tran,Émilie Lecomte,Sylvie Saleün,Suk Namkung,Cécile Robin,Kristina Weber,Eric Devine,Véronique Blouin,Oumeya Adjali,Eduard Ayuso,Guangping Gao,Magalie Penaud‐Budloo,Phillip W.L. Tai	2022	50
8	Overcoming innate immune barriers that impede AAV gene therapy vectors Journal of Clinical Investigation ·Manish Muhuri,Maeda Yukiko,Hong Ma,Sanjay Ram,Katherine A. Fitzgerald,Phillip W.L. Tai,Guangping Gao	2021	134
9	Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo Nature Communications ·Raed Ibraheim,Phillip W.L. Tai,Aamir Mir,Nida Javeed,Jiaming Wang,Tomás Rodríguez,Suk Namkung,Samantha J. Nelson,Eraj Shafiq Khokhar,Esther Mintzer,Stacy A. Maitland,Zexiang Chen,Yueying Cao,Emmanouela Tsagkaraki,Scot A. Wolfe,Dan Wang,Athma A. Pai,Wen Xue,Guangping Gao,Erik J. Sontheimer	2021	80
10	Low-Dose Recombinant Adeno-Associated Virus-Mediated Inhibition of Vascular Endothelial Growth Factor Can Treat Neovascular Pathologies Without Inducing Retinal Vasculitis Human Gene Therapy ·Shun-Yun Cheng,Yongwen Luo,Anneliese Malachi,Jihye Ko,Qin Su,Jun Xie,Bo Tian,Haijiang Lin,Ke Xiao,Qiang Zheng,Phillip W.L. Tai,Guangping Gao,Claudio Punzo	2021	11
11	Rational engineering of a functional CpG-free ITR for AAV gene therapy Gene Therapy ·Xiufang Pan,Yongping Yue,Maria Boftsi,Lakmini P. Wasala,Ngoc Tam Tran,Keqing Zhang,David J. Pintel,Phillip W.L. Tai,Dongsheng Duan	2021	36
12	Viral vector platforms within the gene therapy landscapebreakdown → Signal Transduction and Targeted Therapy ·Jote Bulcha,Yi Wang,Hong Ma,Phillip W.L. Tai,Guangping Gao	2021	902
13	Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties Nature Communications ·Hung-Lun Hsu,Alexander Brown,A.B. Loveland,Anoushka Lotun,Meiyu Xu,Li Luo,Guangchao Xu,Jia Li,Lingzhi Ren,Qin Su,Dominic J. Gessler,Yuquan Wei,Phillip W.L. Tai,А.A. Коростелев,Guangping Gao	2020	40
14	AAV-Genome Population Sequencing of Vectors Packaging CRISPR Components Reveals Design-Influenced Heterogeneity Molecular Therapy — Methods & Clinical Development ·Ngoc Tam Tran,Cheryl Heiner,Kristina Weber,Michael Weiand,Daniella Wilmot,Jun Xie,Dan Wang,Alexander Brown,Sangeetha Manokaran,Qin Su,Maria L. Zapp,Guangping Gao,Phillip W.L. Tai	2020	37
15	Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis Nature Communications ·Yeon-Suk Yang,Jun Xie,Dan Wang,Jung‐Min Kim,Phillip W.L. Tai,Ellen M. Gravallese,Guangping Gao,Jae‐Hyuck Shim	2019	101
16	Adeno-associated Virus Genome Population Sequencing Achieves Full Vector Genome Resolution and Reveals Human-Vector Chimeras Molecular Therapy — Methods & Clinical Development ·Phillip W.L. Tai,Jun Xie,Kaiyuen Fong,Matthew G. Seetin,Cheryl Heiner,Qin Su,Michael Weiand,Daniella Wilmot,Maria L. Zapp,Guangping Gao	2018	62
17	Transcriptome Profiling of Neovascularized Corneas Reveals miR-204 as a Multi-target Biotherapy Deliverable by rAAVs Molecular Therapy — Nucleic Acids ·Yi Lu,Phillip W.L. Tai,Jianzhong Ai,Dominic J. Gessler,Qin Su,Xieyi Yao,Qiang Zheng,Phillip D. Zamore,Xun Xu,Guangping Gao	2017	32
18	Chromatin dynamics regulate mesenchymal stem cell lineage specification and differentiation to osteogenesis Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·Hai Wu,Jonathan A. R. Gordon,Troy W. Whitfield,Phillip W.L. Tai,André J. van Wijnen,Janet L. Stein,Gary S. Stein,Jane B. Lian	2017	55
19	A Scalable and Accurate Method for Quantifying Vector Genomes of Recombinant Adeno-Associated Viruses in Crude Lysate Human Gene Therapy Methods ·Jianzhong Ai,Raed Ibraheim,Phillip W.L. Tai,Guangping Gao	2017	22
20	Short DNA Hairpins Compromise Recombinant Adeno-Associated Virus Genome Homogeneity Molecular Therapy ·Jun Xie,Qin Mao,Phillip W.L. Tai,Ran He,Jianzhong Ai,Qin Su,Ye Zhu,Hong Ma,Jia Li,Shoufang Gong,Dan Wang,Zhen Gao,Mengxin Li,Zhong Li,Heather Zhou,Guangping Gao	2017	71

About Phillip W.L. Tai

Phillip W.L. Tai is a scholar working on Genetics, Molecular Biology and Oncology, having authored 53 papers that have together received 4.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (34 papers), CRISPR and Genetic Engineering (19 papers), RNA Interference and Gene Delivery (14 papers), Viral Infectious Diseases and Gene Expression in Insects (12 papers), RNA Research and Splicing (8 papers), CAR-T cell therapy research (5 papers), Bone Metabolism and Diseases (5 papers) and Molecular Biology Techniques and Applications (4 papers). The work is most often cited by research in Genetics (2.1k citations), Molecular Biology (3.2k citations) and Business and International Management (53 citations). Phillip W.L. Tai has collaborated with scholars based in United States, China and France. Frequent co-authors include Guangping Gao, Dan Wang, Hong Ma, Yi Wang, Jote Bulcha, Jun Xie, Janet L. Stein, Jane B. Lian, André J. van Wijnen and Hai Wu. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact